InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
8
T+90 hit rate
20%
T+90 mean return
-43.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by CASAMENTO CHARLES J, Director. Insider active across 3 companies, notably Relmada Therapeutics, INC.. In total, 22 reports have been logged. Split: 1 buy · 8 sells. Total volume traded: €268k. Activity tracked since 3 May 2021. The latest transaction was filed on 22 October 2024 (Don). Regulator: SEC (Form 4). The full history is free.
Declarations22 total
13,000 shares0Common StockSEC:0001213900-24-089971:0
13,000 shares@ US$2.566.3% of flowCommon StockSEC:0001213900-24-077794:0
Ideal exit: 6 Jun 2025 (T+270)
992 shares@ US$0.6925.3% of flowCommon StockSEC:0001104659-24-034545:0
97 shares@ US$0.762.7% of flowCommon StockSEC:0001104659-24-008885:0
19,633 shares0Common StockSEC:0001104659-24-001440:0
6,536 shares@ US$0.286172.0% of flowCommon StockSEC:0001062993-23-019006:0
10 shares@ US$0.430.2% of flowCommon StockSEC:0001104659-23-101684:0
6,053 shares@ US$0.3099.8% of flowCommon StockSEC:0001104659-23-098422:0
14,000 shares0Common StockSEC:0001104659-23-045771:0
84,745 shares0Common StockSEC:0001104659-23-001225:0
51,583 shares0Common StockSEC:0001104659-22-105940:0
19,800 shares@ US$3.240.0080% mcap12.8% of flowCommon StockSEC:0001213900-22-018207:0
10,000 shares@ US$4.600.0054% mcap8.7% of flowCommon StockSEC:0001213900-21-049820:0
10,000 shares@ US$4.608.2% of flowCommon StockSEC:0001213900-21-049820
10,000 shares@ US$4.600.0054% mcap8.7% of flowCommon StockSEC:0001213900-21-043907:0
10,000 shares@ US$4.608.2% of flowCommon StockSEC:0001213900-21-043907
2,136 shares@ US$31.026211.6% of flowCommon StockSEC:0001213900-21-037273
2,136 shares@ US$31.02620.0078% mcap12.4% of flowCommon StockSEC:0001213900-21-037273:0
520 shares@ US$34.07790.0020% mcap3.2% of flowCommon StockSEC:0001213900-21-030571:0
520 shares@ US$34.07793.2% of flowCommon StockSEC:0001213900-21-030571
3,000 sharesCommon StockSEC:0001213900-21-024716
3,000 shares@ US$38.21570.013% mcap21.1% of flowCommon StockSEC:0001213900-21-024716:0
22 of 22 declarations
About CASAMENTO CHARLES J
Charles J. Casamento is a director at RELMADA THERAPEUTICS, INC. He plays a vital role in overseeing operations and strategy for the company, bringing his expertise to guide growth and efficiency of the organization.
